Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 2374624, 9 pages
https://doi.org/10.1155/2017/2374624
Research Article

Influences of Realgar-Indigo naturalis, A Traditional Chinese Medicine Formula, on the Main CYP450 Activities in Rats Using a Cocktail Method

1Guangdong Pharmaceutical University, Guangzhou 510006, China
2Institute of Radiation Medicine, AMMS, Beijing 100850, China

Correspondence should be addressed to Yue Gao; nc.ca.imb@euyoag and Zeng-Chun Ma; moc.931@nuhczam

Received 27 October 2016; Accepted 19 January 2017; Published 21 March 2017

Academic Editor: Shuang-En Chuang

Copyright © 2017 Huan-Hua Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Micucci, D. Valli, G. Matacchione, and A. Catalano, “Current perspectives between metabolic syndrome and cancer,” Oncotarget, vol. 7, no. 25, pp. 38959–38972, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Wang, X. Zou, and Y. C. Zhang, “From “kidneys govern bones” to chronic kidney disease, diabetes mellitus, and metabolic bone disorder: a crosstalk between traditional chinese medicine and modern science,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 4370263, 8 pages, 2016. View at Publisher · View at Google Scholar
  3. L. Wang, G.-B. Zhou, P. Liu et al., “Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 12, pp. 4826–4831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. L. Lin, J. J. Shan, T. Xie et al., “Application of traditional Chinese medical herbs in prevention and treatment of respiratory syncytial virus,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 6082729, 13 pages, 2016. View at Publisher · View at Google Scholar
  5. X. Zhou, S. W. Seto, D. Chang et al., “Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research,” Frontiers in Pharmacology, vol. 7, article 201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. X. H. Ma, C. J. Zheng, L. Y. Han et al., “Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives,” Drug Discovery Today, vol. 14, no. 11-12, pp. 579–588, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Coombs, M. Tavakkoli, and M. S. Tallman, “Acute promyelocytic leukemia: where did we start, where are we now, and the future,” Blood cancer journal, vol. 5, Article ID e304, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-D. Zhang, G.-Q. Chen, Z.-G. Wang, Z.-Y. Wang, S.-J. Chen, and Z. Chen, “Arsenic trioxide, a therapeutic agent for APL,” Oncogene, vol. 20, no. 49, pp. 7146–7153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-J. Chen, G.-B. Zhou, X.-W. Zhang, J.-H. Mao, H. De Thé, and Z. Chen, “From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia,” Blood, vol. 117, no. 24, pp. 6425–6437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G.-Q. Chen, X.-G. Shi, W. Tang et al., “Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells,” Blood, vol. 89, no. 9, pp. 3345–3353, 1997. View at Google Scholar · View at Scopus
  11. Z.-X. Shen, G.-Q. Chen, J.-H. Ni et al., “Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients,” Blood, vol. 89, no. 9, pp. 3354–3360, 1997. View at Google Scholar · View at Scopus
  12. J. D. Griffin, “Blood's 70th anniversary: arsenic-from poison pill to magic bullet,” Blood, vol. 127, no. 14, pp. 1729–1730, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Huang, “Clinical study on the treatment of acute promyelocytic leukemia with composite Indigo Naturalis tablets,” Chinese Journal of Hematology, vol. 16, p. 3, 1995. View at Google Scholar
  14. Y. Xiang, S.-L. Huang, and A.-X. Guo, “The influence on long-term survey of acute promyelocytic leukemia treated alternatively with compound huangdai tablets and chemotherapy,” Chinese Journal of Clinical Hematology, vol. 16, no. 5, pp. 204–206, 2007. View at Google Scholar
  15. P. Jin, X. Liang, L. Xia et al., “Determination of 20 trace elements and arsenic species for a realgar-containing traditional Chinese medicine Niuhuang Jiedu tablets by direct inductively coupled plasma–mass spectrometry and high performance liquid chromatography–inductively coupled plasma–mass spectrometry,” Journal of Trace Elements in Medicine and Biology, vol. 33, pp. 73–80, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-F. Lu, J.-W. Yan, Q. Wu, J.-Z. Shi, J. Liu, and J.-S. Shi, “Realgar- and cinnabar-containing An-Gong-Niu-Huang Wan (AGNH) is much less acutely toxic than sodium arsenite and mercuric chloride,” Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 134–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Badal, S. A. Williams, G. Huang et al., “Cytochrome P450 1 enzyme inhibition and anticancer potential of chromene amides from Amyris plumieri,” Fitoterapia, vol. 82, p. 6, 2011. View at Google Scholar
  18. M. Ingelman-Sundberg, “Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future,” Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 193–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y.-G. Wang, J.-M. Zhou, Z.-C. Ma et al., “Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury,” Chemico-Biological Interactions, vol. 200, no. 1, pp. 11–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhang, Z. Ma, Q. Liang et al., “Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor,” Journal of Ethnopharmacology, vol. 164, pp. 357–367, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Geng, H. Si, D. Kang et al., “Influences of Re du Ning Injection, a traditional Chinese medicine injection, on the CYP450 activities in rats using a cocktail method,” Journal of Ethnopharmacology, vol. 174, pp. 426–436, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Yang, Y. Wang, Q. Li et al., “Determination of probe concentration of CYP450 isoforms by HPLC,” Chinese Journal of Pharmaceutical Analysis, vol. 35, no. 80, p. 7, 2015. View at Google Scholar
  23. L. Aihua, L. Chunying, W. Jinhua et al., “Toxicity study of realgar,” China Journal of Chinese Materia Medica, vol. 36, no. 14, pp. 1895–1900, 2011. View at Publisher · View at Google Scholar
  24. Y. Lu, J. Shi, J. Shi, and J. Liu, “Safety evaluation of realgar-and cinnabar-containing traditional Chinese medicine,” China Journal of Chinese Materia Medica, vol. 36, no. 24, pp. 3402–3405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Ferron, K. Hogeveen, G. De Sousa et al., “Modulation of CYP3A4 activity alters the cytotoxicity of lipophilic phycotoxins in human hepatic HepaRG cells,” Toxicology in Vitro, vol. 33, pp. 136–146, 2016. View at Publisher · View at Google Scholar · View at Scopus